Rafferty Asset Management
KALV icon

Rafferty Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Rafferty Asset Management’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$530K Buy
2025
Q1 		$303K Sell
2024
Q4 		$461K Buy
2024
Q3 		$508K Buy
2022
Q2 		– Sell
2022
Q1 		$701K Sell
2021
Q4 		$849K Buy
2021
Q3 		$674K Sell
2021
Q2 		$1.43M Buy
2021
Q1 		$470K Buy